{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-043736","form_type":"8-K","ticker":"RCKT","cik":"0001281895","company_name":"ROCKET PHARMACEUTICALS, INC.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.424319+00:00","generated_at":"2026-06-10T18:53:20.156507+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Rocket Pharmaceuticals reduces ATM offering capacity to $180M, suspends sales","bullets":["Original $200M ATM capacity reduced to $180M via amendment to Sales Agreement with Cowen.","Company sold $65.9M of shares to date; remaining availability is ~$114.1M.","ATM prospectus suspended; no further sales until new prospectus or registration statement filed.","Amendment effective September 12, 2023; Amended Sales Agreement remains in full force."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-043736","json":"https://secwatch.observer/filing/0001140361-23-043736.json","markdown":"https://secwatch.observer/filing/0001140361-23-043736.md","text":"https://secwatch.observer/filing/0001140361-23-043736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123043736/0001140361-23-043736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123043736/ny20010507x4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:53:20.156507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"caaef1ac6bb17e01e5a5c065ab8ebdf1135f19e4","claim":"ROCKET PHARMACEUTICALS, INC. amended Sales Agreement with Cowen and Company, LLC valued at $180,000,000 (effective 2023-09-12).","evidence_excerpt":"(the “ Company ”) entered into a sales agreement (the “ Sales Agreement ”) with Cowen and Company, LLC (“ Cowen ”) pursuant to which the Company may, from time to time, sell shares of its common stock, par value $0.01 per","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036123043736/0001140361-23-043736-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cowen and Company, LLC"},{"label":"Value","value":"$180,000,000"},{"label":"Effective","value":"2023-09-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}